Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoints Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Optimizing Treatment Decisions for Acute Demyelinating Optic Neuritis
Development of IMPDH-Targeted Drugs against Crytosporidium
EGFR activity in T cell-influenced glioma invasiveness &chemosensitivity
A Kinetic Study of Inflammation-Induced Hyporetinemia
VCAM-1 in Atherogenesis - Function and Regulation
Recently added grants:
Genomic Predictors of Placebo response in Phase II AUD trials
Towards understanding the role of immune regulation of Apolipoprotein E function in Alzheimer's disease proteostasis
Decision Making Among Older Adults: the AUTO study
Midcareer Investigator Award in Translational Patient-Oriented Research in Aging
Stress, Epigenetics and Aging
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43308-6-0-1
Application #
7587174
Study Section
Project Start
2004-05-15
Project End
2009-05-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/ Washington University
$1,406,468
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
You, Ming /
$1,882,921
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/
Comments
Be the first to comment on this grant